RT Journal Article
SR Electronic
T1 Vaccine Effectiveness against COVID-19 among Symptomatic Persons Aged ≥12 Years with Reported Contact with COVID-19 Cases, February – September 2021
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.30.21267928
DO 10.1101/2021.12.30.21267928
A1 Chung, Jessie R
A1 Kim, Sara S
A1 Belongia, Edward A
A1 McLean, Huong Q
A1 King, Jennifer P
A1 Nowalk, Mary Patricia
A1 Zimmerman, Richard K
A1 Geffel, Krissy Moehling
A1 Martin, Emily T
A1 Monto, Arnold S
A1 Lamerato, Lois E
A1 Gaglani, Manjusha
A1 Hoffman, Eric
A1 Volz, Marcus
A1 Jackson, Michael L
A1 Jackson, Lisa A
A1 Patel, Manish M
A1 Flannery, Brendan
YR 2022
UL http://medrxiv.org/content/early/2022/01/01/2021.12.30.21267928.abstract
AB Individuals in contact with persons with COVID-19 are at high risk of developing COVID-19, but protection offered by COVID-19 vaccines in the context of known exposure is unknown. Symptomatic outpatients reporting acute onset of COVID-19-like illness and tested for SARS-CoV-2 infection were enrolled. Among 2,229 participants, 283/451 (63%) of those reporting contact and 331/1778 (19%) without known contact tested SARS-CoV-2 positive. Using the test-negative design, adjusted vaccine effectiveness was 71% (95% confidence interval, 49%-83%) among fully vaccinated participants reporting contact versus 80% (95% CI, 72%-86%) among those without. This study supports COVID-19 vaccination and highlights the importance of efforts to increase vaccination coverage.Competing Interest StatementMPN reports grants from Merck & Co. outside the submitted work. RKZ reports grants from Sanofi Pasteur outside the submitted work. ETM reports grants from Merck & Co. outside the submitted work and consulting fees from Pfizer. ASM reports consulting fees from Seqirus outside the submitted work. LEL reports grants from Xcenda, Inc., eMAXHealth, AstraZeneca, Pfizer, Evidera outside the submitted work. MLJ reports grants from Sanofi Pasteur. All other authors report nothing to disclose.Funding StatementThis work was supported by the US Centers for Disease Control and Prevention through cooperative agreements U01IP001034-U01IP001039. At Pittsburgh, the project was also supported by the National Institutes of Health through grant ULTR001857.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research activity involving human subjects was reviewed by the Institutional Review Boards (IRB) of the Centers for Disease Control and Prevention (CDC) and Baylor Scott and White Health, Marshfield Clinic Research Institute, University of Michigan, Henry Ford Health System, and University of Pittsburgh and was conducted consistent with applicable federal law and CDC policy (See 45 C.F.R. part 46; 21 C.F.R. part 56). The Kaiser Permanente Washington Health Research Institute IRB determined this activity was research not involving human subjects under a nondisclosure agreement with CDC. Centers for Disease Control and Prevention IRB project determination numbers for included projects: 0900f3eb81c2e791, 0900f3eb81c52dc5; 0900f3eb81c52420, 0900f3eb81bc746b, 6238.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified dataset can be made available upon request